published meta-analysis   sensitivity analysis   studies

Vitamin D in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias deathsdetailed resultsMurai, 2020 1.53 [0.53; 4.43] 1.53[0.53; 4.43]Murai, 202010%237NAnot evaluable hospital dischargedetailed resultsMurai, 2020 0.99 [0.71; 1.38] 0.99[0.71; 1.38]Murai, 202010%240NAnot evaluable mechanical ventilationdetailed resultsMurai, 2020 0.49 [0.21; 1.14] 0.49[0.21; 1.14]Murai, 202010%237NAnot evaluable ICU admissiondetailed resultsMurai, 2020 0.71 [0.37; 1.37] 0.71[0.37; 1.37]Murai, 202010%237NAnot evaluable serious adverse eventsdetailed resultsMurai, 2020 0.99 [0.02; 50.39] 0.99[0.02; 50.39]Murai, 202010%237NAnot evaluable adverse eventsdetailed resultsMurai, 2020 1.99 [0.07; 59.94] 1.99[0.07; 59.94]Murai, 202010%237NAnot evaluable0.25.01.0relative treatment effectwww.metaEvidence.org2024-04-23 20:43 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 734,1439 - roots T: 290